Searched for
KALYANASUNDARAM SUBRAMANIAN
Buy Sun Pharmaceutical Industries, target price Rs 1225: ICICI DirectHigher contribution from specialty and strong domestic franchise is likely to change the product mix towards more remunerative businesses b...- Buy Sun Pharmaceutical Industries, price target Rs 455: Sagar DoshiThe analyst suggested a stoploss at Rs 410 .
- Morgan Stanley maintains overweight on Sun Pharma, target price Rs 530The nature of the observations will be understood once the FDA makes Form 483 public, said Morgan Stanley.
- Buy Sun Pharmaceutical Industries, target Rs 455: Kunal BothraBuy Sun Pharmaceutical Industries Ltd. at a price target of Rs 455.0 and a stoploss at Rs 425 from entry point.
- Buy Sun Pharma, price target Rs 470: Jayesh BhanushaliThe analyst suggested a stoploss at Rs 435.
- Buy Sun Pharma, target Rs 450: CK NarayanBuy Sun Pharmaceutical Industries Ltd. at a price target of Rs 450.0 and a stoploss at Rs 433 from entry point.
- Buy Sun Pharma, target price Rs 434: Jay ThakkarJay Thakkar recommended to keep stoploss at Rs 408.
- Sell Sun Pharma, target Rs 395: Shubham AggarwalSell Sun Pharmaceutical Industries Ltd. at a price target of Rs 395.0 and a stoploss at Rs 422 from entry point.
- Buy Sun Pharmaceutical Industries, target Rs 655: Gaurav RatnaparkhiBuy Sun Pharmaceutical Industries at a price target of Rs 655 and a stop loss at Rs 588 from the entry point.
- Buy Sun Pharmaceutical Industries, target Rs 520: Manas JaiswalBuy Sun Pharmaceutical Industries Ltd. at a price target of Rs 520.0 and a stop loss at Rs 502 from entry point.
- Buy Sun Pharmaceutical Industries, target Rs 640: Kunal BothraBuy Sun Pharmaceutical Industries Ltd. at a price target of Rs 640.0 and a stop loss at Rs 550 from entry point.
- Sell Sun Pharmaceutical Industries, target Rs 543.60: ICICI DirectSell Sun Pharmaceutical Industries Ltd. at a price target of Rs 543.6 and a stop loss at Rs 559.4 from entry point.
- Buy Sun Pharmaceutical Industries, target Rs 634: Sagar DoshiBuy Sun Pharmaceutical Industries Ltd. at a price target of Rs 634.0 and a stop loss at Rs 575 from entry point.
- Buy Sun Pharmaceutical Industries, target Rs 610: Shrikant ChouhanBuy Sun Pharmaceutical Industries Ltd. at a price target of Rs 610.0 and a stop loss at Rs 565 from entry point.
- Buy Sun Pharmaceutical Industries, target Rs 530: Shrikant ChouhanBuy Sun Pharmaceutical Industries at a price target of Rs 530 and a stop loss at Rs 498 from entry point.
- Buy Sun Pharmaceutical Industries, target Rs 585: Shrikant ChouhanBuy Sun Pharmaceutical Industries at a price target of Rs 585 and a stop loss at Rs 553 from entry point.
- Buy Sun Pharmaceutical Industries, target Rs 550: Manas JaiswalBuy Sun Pharmaceutical Industries at a price target of Rs 550 and a stop loss at Rs 520 from entry point.
- Sell Sun Pharmaceutical Industries target Rs 519: Siddharth BhamreSell Sun Pharmaceutical Industries Ltd. at a price target of Rs 519 and a stop loss at Rs 588 from entry point.
- Sun Pharma brings back old hand Kalyanasundaram Subramanian from Taro Pharmaceutical IndustriesThe decision to bring back Sundaram from Taro signals a move that's possibly aimed at shaping the next stage of growth for India's largest ...
- IISc professor’ virtual liver product gets patent in USThe virtual liver mimics normal liver functions and generates likely outcomes of new drugs before the drug is tested on animals and humans.
Load More
